ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

ISG to Study Medical Device Digital Service Providers

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Upcoming ISG Provider Lens® report will evaluate providers embedding AI-based capabilities into medical devices to improve patient care

Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm, has launched a research study examining service providers that help medical device companies adopt new technologies and enhance their products.

The study results will be published in a series of comprehensive ISG Provider Lens® reports, called Medical Device Digital Services, scheduled to be released in October 2026. The reports will cover companies offering services that support digital engineering, regulatory compliance, quality assurance and post-market digital and AI enablement.

Enterprise buyers will be able to use information from the reports to evaluate their current vendor relationships, potential new engagements and available offerings, while ISG advisors use the information to recommend providers to the firm’s buy-side clients.

The medical device sector is evolving quickly as demand rises for smarter, more connected and more patient-focused healthcare solutions. Enterprises are integrating AI, cloud and IoT features into medical devices to generate real-time insights and enable better treatment decisions. AI is entering an early scaling phase and becoming a key driver of innovation, especially in post-market enablement. This shift is moving the industry from traditional hardware-centric products to more data-driven solutions. It is also introducing challenges related to data management, system compatibility and regulatory compliance.

“Medical device firms recognize that they need stronger outside support to navigate growing technological and regulatory complexity,” said Iain Fisher, director, ISG. “They are partnering with service providers to accelerate product development and strengthen compliance. Leading providers contribute AI expertise, scalable delivery models and innovation that help clients roll out new solutions faster and more efficiently.”

ISG has distributed surveys to more than 100 medical device digital service providers. Working in collaboration with ISG’s global advisors, the research team will produce three quadrants representing the medical device digital service the typical enterprises are buying, based on ISG’s experience working with its clients. The three quadrants are:

  • Digital Engineering and Product Development, evaluating providers that deliver end-to-end digital engineering and product development services. These providers are assessed on their ability to support the design, development and enhancement of connected, software-driven medical devices.
  • Regulatory Compliance, Strategy and Quality Assurance, assessing providers of services that enhance compliance, strategic insight and product quality. Providers are evaluated on their ability to navigate global regulatory frameworks while aligning digital and engineering initiatives with go-to-market objectives.
  • AI and Innovation Driving Post-Market Digital Enablement, covering providers delivering AI-based and other digital solutions for post-market activities of medical device manufacturers. These providers enable real-time device monitoring and performance tracking to ensure continuous product improvement and patient safety.

Geographically focused reports from the study will cover the global medical device digital service market and examine products and services available in the US and Europe. ISG analysts Rohan Sinha (U.S.) and Sneha Jayanth (Europe) will serve as authors of the reports.

A list of identified providers and vendors and further details on the study are available in this digital brochure. Companies not listed as medical device digital service providers can contact ISG and ask to be included in the study.

All 2026 ISG Provider Lens® evaluations feature expanded customer experience (CX) data that measures actual enterprise experience with specific provider services and solutions, based on ISG’s continuous CX research.

About ISG

ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world’s top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data and research, in-depth knowledge and governance of provider ecosystems, and the expertise of its 1,500 professionals worldwide working together to help clients maximize the value of their technology investments.

Medical device firms recognize that they need stronger outside support to navigate growing technological and regulatory complexity. They are partnering with service providers to accelerate product development and strengthen compliance.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  248.28
-2.28 (-0.91%)
AAPL  273.05
+2.82 (1.04%)
AMD  274.95
-3.44 (-1.24%)
BAC  53.95
+0.04 (0.07%)
GOOG  335.40
-4.00 (-1.18%)
META  670.91
-17.64 (-2.56%)
MSFT  418.07
-4.72 (-1.12%)
NVDA  202.06
+0.38 (0.19%)
ORCL  177.58
+2.52 (1.44%)
TSLA  392.50
-8.12 (-2.03%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.